UT Health San Antonio | The University of Texas Health Science Center at San Antonio

First Word Pharma: Press Release Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Noboru Hiroi, PhD, professor, Department of Pharmacology, was quoted in this article.   Read More

Share This Story